BAYSTATE MEDICAL CENTER
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $6.1M
- Transactions
- 1,113
- Companies
- 40
- Average per transaction
- $5,476
Who reported the payments
| Medtronic | $1,005,320 |
| Eli Lilly | $729,167 |
| Genentech, Inc. | $539,618 |
| Roche Products Limited | $478,860 |
| Occlutech US LLC | $375,535 |
| M.a. Med Alliance S.A. | $334,693 |
| GSK | $216,999 |
| AstraZeneca | $204,124 |
| Coloplast | $156,457 |
| Rhythm Pharmaceuticals, Inc. | $127,222 |
| Bristol Myers Squibb | $116,923 |
| ZOLL Medical Corporation | $93,005 |
| Hoffmann-la Roche Limited | $85,152 |
| Microvention, Inc. | $81,600 |
| ZOLL Circulation Inc | $78,579 |
| Tesaro, Inc. | $75,309 |
| Dompe Farmaceutici S.p.a. | $71,187 |
| Sanofi US Services Inc. | $70,955 |
| Biotronik Inc. | $68,381 |
| Daiichi Sankyo Inc. | $63,087 |
| Sanofi | $61,955 |
| AbbVie | $56,839 |
| Boston Scientific | $53,000 |
| Insmed, Inc. | $51,328 |
| Amgen | $50,948 |
| Gilead | $45,416 |
| Pfizer | $43,289 |
| Astrazeneca UK Limited | $41,086 |
| Chiesi USA, Inc. | $37,672 |
| Indivior Inc. | $37,378 |
| Takeda Pharmaceuticals U.S.A., Inc. | $36,200 |
| Stryker | $32,894 |
| Boehringer Ingelheim | $32,730 |
| Cytyc Corporation | $31,025 |
| Ferring International Pharmascience Center US | $30,294 |
| Veru Inc. | $29,700 |
| Janssen Research & Development, LLC | $29,700 |
| Viiv Healthcare Company | $26,983 |
| E.r. Squibb & Sons, L.L.C. | $26,899 |
| Shockwave Medical, Inc | $26,300 |